# ClinicalTrials.gov record NCT03891875

> PeptideScanner retained ClinicalTrials.gov record NCT03891875 at 2026-07-30T18:42:56.626Z. Its registry update date was 2024-07-12, and PeptideScanner's reviewed identity mapping was elamipretide.

- Evidence object: `story:clinicaltrials-gov-nct03891875-elamipretide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-07-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03891875-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03891875-elamipretide-v1.json
- Content SHA-256: `8df980f4ad997015a79b1080a980d0440fca225f6aa983299392eb9ab817db58`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03891875 ([`ctg-observation-nct03891875-2024-07-12-a15d2d662536`](#source-ctg-observation-nct03891875-2024-07-12-a15d2d662536))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03891875 at 2026-07-30T18:42:56.626Z. Its registry update date was 2024-07-12, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct03891875-2024-07-12-a15d2d662536`](#source-ctg-observation-nct03891875-2024-07-12-a15d2d662536))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03891875 at 2026-07-30T18:42:56.626Z. Its registry update date was 2024-07-12, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct03891875-2024-07-12-a15d2d662536`](#source-ctg-observation-nct03891875-2024-07-12-a15d2d662536))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03891875-2024-07-12-a15d2d662536`](#source-ctg-observation-nct03891875-2024-07-12-a15d2d662536))

## Sources

<a id="source-ctg-observation-nct03891875-2024-07-12-a15d2d662536"></a>
- **ClinicalTrials.gov record NCT03891875 · retained source version 2024-07-12:a15d2d662536c59e9f78ed371efc5bf11adc4e629f58b1be04fbf605ad1110a6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03891875) (`ctg-observation-nct03891875-2024-07-12-a15d2d662536`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03891875." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03891875-elamipretide-v1.json SHA-256: 8df980f4ad997015a79b1080a980d0440fca225f6aa983299392eb9ab817db58.